Challenges and Solutions in Managing Umbilical Myiasis With Sepsis in a Newborn

Area of Science:

• Medical Entomology
• Parasitology
• Neonatal Care

Background:

• Myiasis, a parasitic infestation by fly larvae, is prevalent in tropical, rural, and low socioeconomic settings.
• Umbilical myiasis is a rare presentation in neonates, potentially leading to severe complications like Staphylococcus aureus sepsis.

Purpose of the Study:

• To report a rare case of neonatal umbilical myiasis.
• To evaluate the efficacy and safety of oral ivermectin in treating neonatal umbilical myiasis.
• To emphasize the need for further research on ivermectin use in low-weight children.

Main Methods:

• A neonate with umbilical myiasis and sepsis was treated with oral ivermectin (200 μg/kg).
• Larval presence and adverse events were monitored.
• Treatment efficacy was assessed by the absence of larvae and complications.

Main Results:

• Oral ivermectin administration led to the complete resolution of larvae within two days.
• No adverse events were observed following ivermectin treatment.
• Delayed treatment due to safety concerns for low-weight children prolonged hospitalization.

Conclusions:

• Neonatal umbilical myiasis signifies poor hygiene and socioeconomic vulnerability.
• Ivermectin shows promise for treating neonatal myiasis, but further safety studies in children under 15 kg are crucial.
• Evidence-based guidelines are needed for optimal management of neglected parasitic diseases in vulnerable pediatric populations.